7Baggers
 iterum therapeutics sees cash runway into 2026  Yahoo Finance Sat, 20 Sep 2025 07:00:00 GMT
 iterum therapeutics rises on patent wins, uti drug launch progress  TradingView Fri, 19 Sep 2025 12:59:09 GMT
 iterum therapeutics provides business update  Yahoo Finance Fri, 19 Sep 2025 12:00:00 GMT
 iterum therapeutics sees cash runway into 2026  TipRanks Fri, 19 Sep 2025 07:00:00 GMT
 published on: 2025-09-13 17:05:25  newser.com Sat, 13 Sep 2025 22:05:25 GMT
 iterum therapeutics faces nasdaq delisting notice  MSN Fri, 12 Sep 2025 02:48:51 GMT
 iterum therapeutics faces nasdaq delisting notice  MSN Thu, 11 Sep 2025 18:39:40 GMT
 Iterum Therapeutics Faces Shareholder Pushback on Key Proposals  The Globe and Mail Thu, 11 Sep 2025 07:00:00 GMT
 iterum therapeutics launches new antibiotic orlynvah  MSN Wed, 10 Sep 2025 12:47:32 GMT
 Iterum Therapeutics Faces Shareholder Pushback on Key Proposals  TipRanks Wed, 10 Sep 2025 07:00:00 GMT
 iterum therapeutics faces nasdaq delisting notice  MSN Sun, 07 Sep 2025 16:05:10 GMT
 published on: 2025-09-04 05:04:19  Newser Thu, 04 Sep 2025 10:04:19 GMT
 iterum therapeutics faces nasdaq delisting notice  MSN Wed, 03 Sep 2025 15:51:51 GMT
 published on: 2025-09-03 08:52:33  Newser Wed, 03 Sep 2025 13:52:33 GMT
 published on: 2025-09-02 04:10:13  Newser Tue, 02 Sep 2025 09:10:13 GMT
 published on: 2025-08-31 17:16:14  Newser Sun, 31 Aug 2025 22:16:14 GMT
 published on: 2025-08-30 04:36:06  Newser Sat, 30 Aug 2025 09:36:06 GMT
 published on: 2025-08-29 05:11:46  Newser Fri, 29 Aug 2025 10:11:46 GMT
 published on: 2025-08-29 03:38:25  Newser Fri, 29 Aug 2025 08:38:25 GMT
 Iterum Therapeutics Faces Nasdaq Delisting Notice  The Globe and Mail Fri, 29 Aug 2025 07:00:00 GMT
 Iterum Launches First Oral Penem Antibiotic for UTIs in the US  Medical Dialogues Fri, 29 Aug 2025 07:00:00 GMT
 Iterum Therapeutics Faces Nasdaq Delisting Notice  TipRanks Thu, 28 Aug 2025 07:00:00 GMT
 iterum therapeutics launches new antibiotic orlynvah  MSN Thu, 28 Aug 2025 05:42:46 GMT

Iterum Therapeutics plc
(NASDAQ:ITRM) 

ITRM stock logo

Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials ...

Founded: 2015
Full Time Employees: 44
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends